HS code · 6-digit subheading
HS Code 3002.15 – Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale
HS code 3002.15 is the 6-digit subheading for blood, human or animal, antisera, other blood fractions and immunological products, immunological products, put up in measured doses or in forms or packings for retail sale. It is used for monoclonal antibodies (single, retail), recombinant human insulin (retail), erythropoietin (EPO) injections (retail), granulocyte-colony stimulating factor (G-CSF) injections (retail) and interferon alpha/beta injections (retail).
What HS 3002.15 covers
This HS code encompasses immunological products, whether human or animal-derived, that are prepared in measured doses or packaged for retail sale, and are *not* mixed. This category includes a wide array of finished biopharmaceutical products, such as single-component monoclonal antibodies, recombinant proteins, or specific immunoglobulins, ready for direct administration to patients. These are high-value, often prescription-only medicines used to treat various diseases, including autoimmune disorders, cancers, and infectious diseases. Importers are typically national health systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are leading global pharmaceutical and biotechnology companies. The trade is heavily regulated, requiring extensive clinical trials and marketing authorizations. Supply chain management is critical, involving cold chain logistics and secure distribution to ensure product efficacy and patient safety.
- Covers
- Monoclonal antibodies (single, retail)
- Recombinant human insulin (retail)
- Erythropoietin (EPO) injections (retail)
- Granulocyte-colony stimulating factor (G-CSF) injections (retail)
- Interferon alpha/beta injections (retail)
- Immunoglobulin G (single, retail)
- Diagnostic reagents (immunological, single, retail)
- Examples
- Humira (adalimumab)
- Enbrel (etanercept)
- Remicade (infliximab)
- Herceptin (trastuzumab)
- Avastin (bevacizumab)
- Epogen (epoetin alfa)
- Neupogen (filgrastim)
Codes often confused with 3002.15
Common mistake. This code is distinguished from 300214 by covering *unmixed* immunological products in retail packaging, whereas 300214 is for *mixed* products. It is also separate from vaccines (300241/300242).
Top exporters and importers of HS code 300215, 2025
In 2025, the largest exporter of HS code 300215 in UN Comtrade data was Switzerland, with 27% of world exports; the largest importer in UN Comtrade data was the United States, with 35% of world imports. Countries that did not report 2025 data are estimated from partner records, which can understate them.
Top exporters 2025 · share of world exports
- 1 Switzerland $58.5B 27% of world exports
- 2 Germany $37.1B 17% of world exports
- 3 Ireland $27.9B 13% of world exports
World total: $214.5B Reported figures on UN Comtrade ↗
Top importers 2025 · share of world imports
- 1 United States $78.7B 35% of world imports
- 2 Germany $18.5B 8.1% of world imports
- 3 Switzerland $13.0B 5.7% of world imports
World total: $227.7B Reported figures on UN Comtrade ↗
How these figures are built
109 countries reported 2025 trade to UN Comtrade in HS 2022, and their own totals are used. Countries that did not report are estimated from what other countries recorded trading with them. Those estimates miss trade with other non-reporting countries, so they can be low, and a non-reporting country can rank higher than shown or be missing from the list. World totals add both and leave out trade between two non-reporting countries. Figures are in current US dollars; reported imports are mostly valued CIF and exports FOB, and exports include re-exports. The UN Comtrade links show the underlying records; they can also list a few reporters left out here (regional groups and older HS editions).
Source: UN Comtrade (United Nations Statistics Division), 2025 annual data.
Brazil NCM codes for 3002.15 3
Brazil splits HS 3002.15 into 3 NCM codes, Mercosur's 8-digit tariff lines.
- 3002.15.10 Interferon beta; peginterferon alfa-2abetainterferona; alfapeginterferona 2a
- 3002.15.20 Rituximab, trastuzumab and other listed biologicsBasiliximab (DCI); bevacizumab (DCI); daclizumab (DCI); etanercept (DCI); gemtuzumab ozogamicin (DCI); oprelvekin (DCI); rituximab (DCI); trastuzumab (DCI)
- 3002.15.90 Other immunological products in doses or retailOutros
All Brazil NCM codes in heading 30.02 →
Source: Siscomex NCM table, updated Oct 2026. The Portuguese text is official; the English is our translation.
Questions about HS 3002.15
What is HS code 300215?
HS code 300215 is a 6-digit subheading in the Harmonized System that covers: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale. This HS code encompasses immunological products, whether human or animal-derived, that are prepared in measured doses or packaged for retail sale, and are *not* mixed. This category includes a wide array of finished biopharmaceutical products, such as single-component monoclonal antibodies, recombinant proteins, or specific immunoglobulins, ready for direct administration to patients. These are high-value, often prescription-only medicines used to treat various diseases, including autoimmune disorders, cancers, and infectious diseases. Importers are typically national health systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are leading global pharmaceutical and biotechnology companies. The trade is heavily regulated, requiring extensive clinical trials and marketing authorizations. Supply chain management is critical, involving cold chain logistics and secure distribution to ensure product efficacy and patient safety.
What products fall under HS code 300215?
Monoclonal antibodies (single, retail), Recombinant human insulin (retail), Erythropoietin (EPO) injections (retail), Granulocyte-colony stimulating factor (G-CSF) injections (retail), Interferon alpha/beta injections (retail), Immunoglobulin G (single, retail), Diagnostic reagents (immunological, single, retail)
What are common misclassifications for HS code 300215?
This code is distinguished from 300214 by covering *unmixed* immunological products in retail packaging, whereas 300214 is for *mixed* products. It is also separate from vaccines (300241/300242).
Which countries are the top exporters of goods under HS code 300215?
In 2025, the top exporters of HS code 300215 in UN Comtrade data were Switzerland ($58.5B, 27% of world exports), Germany ($37.1B) and Ireland ($27.9B). World exports came to about $214.5B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
Which countries are the top importers of goods under HS code 300215?
In 2025, the top importers of HS code 300215 in UN Comtrade data were the United States ($78.7B, 35% of world imports), Germany ($18.5B) and Switzerland ($13.0B). World imports came to about $227.7B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
How is HS code 300215 structured?
HS code 300215 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (02) identify the heading, and digits 5-6 (15) specify the subheading. This code is standardized globally by the World Customs Organization.
What is the Brazil NCM code for HS code 300215?
Brazil splits HS code 300215 into 3 NCM codes: 3002.15.10 (Interferon beta; peginterferon alfa-2a), 3002.15.20 (Rituximab, trastuzumab and other listed biologics), 3002.15.90 (Other immunological products in doses or retail). The first 6 digits of each match the HS code.